Punctuated Evolution of Prostate Cancer Genomes
暂无分享,去创建一个
A. Sivachenko | K. Cibulskis | S. Gabriel | E. Lander | T. Golub | G. Getz | M. Meyerson | P. Kantoff | M. Rubin | O. Elemento | R. Onofrio | K. Ardlie | W. Winckler | M. Lawrence | S. Carter | L. Garraway | M. Berger | A. Tewari | E. Nickerson | A. Sboner | M. Ghandi | H. Beltran | G. Kryukov | Y. Drier | A. Ramos | D. Auclair | G. Saksena | Douglas Voet | Sylvan C. Baca | C. Guiducci | J. Mosquera | T. D. Soong | T. Macdonald | F. Demichelis | Naoki Kitabayashi | C. Barbieri | A. Romanel | Michelle Cipicchio | E. Allen | D. Prandi | J. Theurillat | G. Boysen | Kyung Park | S. Baca | Jean-Philippe P. Theurillat | K. Park
[1] A. Sivachenko,et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.
[2] A. McKenna,et al. Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia , 2012, Cell.
[3] S. Gabriel,et al. Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability , 2012, Genome research.
[4] Stephen P. Jackson,et al. Chromothripsis and cancer: causes and consequences of chromosome shattering , 2012, Nature Reviews Cancer.
[5] J. Brooks,et al. Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness , 2012, Oncogene.
[6] J. Lindberg,et al. Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer , 2012, Oncogene.
[7] A. Børresen-Dale,et al. The Life History of 21 Breast Cancers , 2012, Cell.
[8] M. Rubin,et al. Oncogene-mediated alterations in chromatin conformation , 2012, Proceedings of the National Academy of Sciences.
[9] L. Garraway,et al. The genomic landscape of prostate cancer , 2012, Front. Endocrin..
[10] A. Sivachenko,et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer , 2012, Nature Genetics.
[11] A. McKenna,et al. Absolute quantification of somatic DNA alterations in human cancer , 2012, Nature Biotechnology.
[12] Benjamin J. Raphael,et al. The Mutational Landscape of Lethal Castrate Resistant Prostate Cancer , 2016 .
[13] David R. Kelley,et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks , 2012, Nature Protocols.
[14] David T. W. Jones,et al. Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations , 2012, Cell.
[15] Susumu Goto,et al. KEGG for integration and interpretation of large-scale molecular data sets , 2011, Nucleic Acids Res..
[16] S. De,et al. DNA replication timing and long-range DNA interactions predict mutational landscapes of cancer genomes , 2011, Nature Biotechnology.
[17] Stephen J. Salipante,et al. Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers , 2011, Proceedings of the National Academy of Sciences.
[18] Kristian Cibulskis,et al. ContEst: estimating cross-contamination of human samples in next-generation sequencing data , 2011, Bioinform..
[19] A. McKenna,et al. The Mutational Landscape of Head and Neck Squamous Cell Carcinoma , 2011, Science.
[20] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[21] Wei Yan,et al. Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer. , 2011, Cancer cell.
[22] G. Getz,et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.
[23] M. DePristo,et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.
[24] Gerald C. Chu,et al. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression , 2011, Nature.
[25] N. Carter,et al. Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development , 2011, Cell.
[26] Helga Thorvaldsdóttir,et al. Integrative Genomics Viewer , 2011, Nature Biotechnology.
[27] Eric S. Lander,et al. The genomic complexity of primary human prostate cancer , 2010, Nature.
[28] Mark Gerstein,et al. Bioinformatics Applications Note Gene Expression Rseqtools: a Modular Framework to Analyze Rna-seq Data Using Compact, Anonymized Data Summaries , 2022 .
[29] María Martín,et al. Ongoing and future developments at the Universal Protein Resource , 2010, Nucleic Acids Res..
[30] Damian Szklarczyk,et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored , 2010, Nucleic Acids Res..
[31] Mary Goldman,et al. The UCSC Genome Browser database: update 2011 , 2010, Nucleic Acids Res..
[32] Mingming Jia,et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..
[33] Dennis C. Friedrich,et al. A scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries , 2011, Genome Biology.
[34] M. Shen,et al. Molecular genetics of prostate cancer: new prospects for old challenges. , 2010, Genes & development.
[35] Martin J. Aryee,et al. Androgen-induced TOP2B mediated double strand breaks and prostate cancer gene rearrangements , 2010, Nature Genetics.
[36] S. Dalton,et al. Evolutionarily conserved replication timing profiles predict long-range chromatin interactions and distinguish closely related cell types. , 2010, Genome research.
[37] Zhaohui S. Qin,et al. An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. , 2010, Cancer cell.
[38] Yuh-Hwa Wang,et al. Secondary structure formation and DNA instability at fragile site FRA16B , 2010, Nucleic acids research.
[39] Jie Zhang,et al. Nuclear Receptor-Induced Chromosomal Proximity and DNA Breaks Underlie Specific Translocations in Cancer , 2009, Cell.
[40] Michael T. McManus,et al. Chd1 regulates open chromatin and pluripotency of embryonic stem cells , 2009, Nature.
[41] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[42] M. Gerstein,et al. Distinct genomic aberrations associated with ERG rearranged prostate cancer , 2009, Genes, chromosomes & cancer.
[43] Akhilesh Pandey,et al. Human Protein Reference Database and Human Proteinpedia as discovery tools for systems biology. , 2009, Methods in molecular biology.
[44] S. Srivastava,et al. TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation , 2008, Oncogene.
[45] Obi L. Griffith,et al. ORegAnno: an open-access community-driven resource for regulatory annotation , 2007, Nucleic Acids Res..
[46] S. Dhanasekaran,et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer , 2007, Nature.
[47] M. Rubin,et al. TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion , 2006, The American journal of surgical pathology.
[48] I. Jurisica,et al. Unequal evolutionary conservation of human protein interactions in interologous networks , 2007, Genome Biology.
[49] J. Tchinda,et al. TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. , 2006, Cancer research.
[50] J. Tchinda,et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. , 2006, Science.
[51] Jason A. Koutcher,et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis , 2005, Nature.
[52] O. Halvorsen,et al. Combined loss of PTEN and p27 expression is associated with tumor cell proliferation by Ki-67 and increased risk of recurrent disease in localized prostate cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[53] Elizabeth M. Smigielski,et al. dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..
[54] R. Cardiff,et al. Roles for Nkx3.1 in prostate development and cancer. , 1999, Genes & development.
[55] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[56] James Kennedy,et al. Particle swarm optimization , 2002, Proceedings of ICNN'95 - International Conference on Neural Networks.
[57] L. Liotta,et al. Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. , 1995, Cancer research.
[58] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[59] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[60] S. Holm. A Simple Sequentially Rejective Multiple Test Procedure , 1979 .
[61] S. Gould,et al. Punctuated equilibria: the tempo and mode of evolution reconsidered , 1977, Paleobiology.